ÌÇÐÄvlog´«Ã½

Complex Injectables Market Analysis

The Global Complex Injectables Market size is estimated at USD 102.52 billion in 2024, and is expected to reach USD 154.27 billion by 2029, growing at a CAGR of 8.52% during the forecast period (2024-2029).

The complex injectables market is projected to be driven by factors such as a surge in chronic diseases such as cancer and cardiovascular diseases coupled with technological advancements in drug delivery systems. Moreover, the growing demand for biologics and supportive regulatory frameworks with increasing regulatory approvals are further projected to drive market growth over the coming years.

The rising prevalence of chronic diseases significantly drives the demand for complex injectable products. For example, the American Cancer Society reported a surge in estimated new cancer cases, climbing from 1.9 million in 2023 to 2.0 million in 2024. In 2023, the predominant cancers diagnosed included breast, lung, and hematological malignancies.

Similarly, according to the estimates from the National Cancer Institute of Brazil, around 704 thousand new cancer cases are expected to be diagnosed between 2023 and 2025, except non-melanoma skin cancer. Thus, such an alarming burden of cancer is projected to accelerate the development of advanced drug delivery solutions, thereby fueling the demand for complex injectables market.

The increased demand for complex injectables in managing different chronic conditions and the higher safety associated with their usage is expected to uphold their demand over the study period, thereby supporting the market growth. For instance, according to an article published in Drug Delivery and Translational Research in August 2023, the demand for complex injectable products has increased owing to their effectiveness in managing unmet needs in advanced stages of chronic diseases.

In addition, the above article also highlighted that novel parenteral products, including microspheres, nanoparticles, suspensions, and liposomes, improved the safety and delivery of complex injectable products. Therefore, such benefits associated with complex injectables and their roles in drug delivery are expected to propel their acceptance, supporting market expansion.

Additionally, the significant roles of complex injectables in improving therapeutic concentrations of drug products are expected to offer growth momentum for complex injectable formulations, including liposomes and microparticles, thereby augmenting industry uptake. For instance, according to an article published by Cancer Nanotechnology in May 2024, liposome-based drug delivery showed improved tumor-targeting ability of anticancer drugs and increased accumulation of drugs at the tumor site. Therefore, such an efficient site-targeting capability of complex injectables is projected to accelerate development activities, thereby boosting market growth.

Furthermore, the increased efforts from market players to develop advanced complex injectable offerings are further likely to augment the industry growth. For instance, in December 2023, Zydus Worldwide DMCC entered into a licensing agreement with Daewoong Pharmaceutical Co Ltd to co-develop and commercialize Leuprolide Acetate for Depot Suspension in six dosage strengths for the U.S. market. Hence, such efforts undertaken by key market players to expand the availability of complex injectables are likely to support industry expansion over the coming years.

Therefore, the factors mentioned above are expected to boost market growth. In contrast, the complicated manufacturing process of complex injectables and the high cost of products are expected to impede market growth over the coming years.

Complex Injectables Market Trends

The Cancer Segment is Expected to Register a Significant Growth Rate Over the Forecast Period

Complex Injectables Industry Segmentation

As per the report’s scope, a complex injectable comprises an intricate active ingredient, formulation, delivery route, or combination of drug devices. These injectables are designed to administer a therapeutic agent via a hollow needle and syringe, penetrating the skin to deliver the substance into the body.

The market is segmented by route of administration, formulation, drug molecule, application, and geography. Based on the route of administration, the market is segmented into intramuscular (IM), intravenous (IV), and subcutaneous. The market is segmented based on formulation into liposomes, microspheres, and other formulations. Based on drug molecule, the market is segmented into, leuprolide, octreotide, paclitaxel, pegasparagase, risperidone, and others. By application, the market is segmented into cardiovascular, cancer, central nervous system disorders, diabetes, endocrinology, and other disorders. By geography, the market is segmented as North America, Europe, Asia Pacific, Middle East and Africa, and South America. The report also covers the market sizes and forecasts for the complex injectables market in major countries across different regions. The market size is provided for each segment in terms of value (USD).